Sangamo Therapeutics Inc (NASDAQ: SGMO) Slashes -7.17%: The Most Likely Path Going Forward

Sangamo Therapeutics Inc (NASDAQ:SGMO) shares, rose in value on Wednesday, April 16, with the stock price down by -7.17% to the previous day’s close as strong demand from buyers drove the stock to $0.69.

Actively observing the price movement in the last trading, the stock closed the session at $0.74, falling within a range of $0.6715 and $0.738. The value of beta (5-year monthly) was 1.577. Referring to stock’s 52-week performance, its high was $3.18, and the low was $0.30. On the whole, SGMO has fluctuated by -19.00% over the past month.

With the market capitalization of Sangamo Therapeutics Inc currently standing at about $153.99 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-16.

Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that SGMO’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.

The stock’s technical analysis shows that the price of SGMO currently trading nearly -7.05% and -25.27% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 41.31, while the 7-day volatility ratio is showing 8.62% which for the 30-day chart, stands at 13.86%. Furthermore, Sangamo Therapeutics Inc (SGMO)’s beta value is 1.42, and its average true range (ATR) is 0.10.

A comparison of Sangamo Therapeutics Inc (SGMO) with its peers suggests the former has fared considerably weaker in the market. SGMO showed an intraday change of -7.17% in last session, and over the past year, it grew by 23.46%%.

Data on historical trading for Sangamo Therapeutics Inc (NASDAQ:SGMO) indicates that the trading volumes over the past 10 days have averaged 14.86 and over the past 3 months, they’ve averaged 6.61 million. According to company’s latest data on outstanding shares, there are 224.71 million shares outstanding.

Nearly 4.50% of Sangamo Therapeutics Inc’s shares belong to company insiders and institutional investors own 27.74% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 25.52 million shares as on 2025-03-31, resulting in a short ratio of 4.51. According to the data, the short interest in Sangamo Therapeutics Inc (SGMO) stood at 1142.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 26.5 million. The stock has fallen by -32.81% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SGMO stock heading into the next quarter.

Most Popular